Symbol: |
PDZD8
|
Description: |
PDZ domain containing 8 [Source:HGNC Symbol;Acc:26974]
|
Location: |
Chr10:119040000-119134978[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:135
Gene |
Compound |
Gen_sig |
Exp_pattern |
PDZD8 |
NSC 37031 |
0.006 |
Up |
PDZD8 |
NSC 382006 |
0.036 |
Up |
PDZD8 |
Phenol, 2,2'-methylenebis[5-chloro- |
0.031 |
Up |
PDZD8 |
NSC 401101 |
0.027 |
Up |
PDZD8 |
NSC 49789 |
0.014 |
Up |
PDZD8 |
9-AC |
0.027 |
Up |
PDZD8 |
RAPAMYCIN PRODRUG |
0.009 |
Up |
PDZD8 |
Camptothecin hemisuccinate sodium salt |
0.047 |
Up |
PDZD8 |
Camptothecin lysinate HCl |
0.011 |
Up |
PDZD8 |
Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- |
0.041 |
Up |
PDZD8 |
Naphtho[2,3-d]thiazole-4,9-dione, 2-[(4-nitrophenyl) amino]- |
0.009 |
Up |
PDZD8 |
L-Lysine, N-[(methylamino)carbonyl]-N'-(phenylmethoxy- carbonyl)-, phenylmethyl ester |
0.001 |
Up |
PDZD8 |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.032 |
Up |
PDZD8 |
Naphthalene-1,2-dione, 1,2-dihydro- 4-[(2-phenylethyl)amino]- |
0.017 |
Up |
PDZD8 |
NSC 641594 |
0.03 |
Up |
Expression pattern: Sensitivity / Resistance
Total:9 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:6
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:5
Gene |
Gen_transcript |
miRNA |
miR_location |
PDZD8 |
ENST00000334464 |
hsa-mir-100-5p |
Chr11:122022983-122023004[-] |
PDZD8 |
ENST00000334464 |
hsa-mir-380-5p |
Chr14:101491358-101491379[+] |
PDZD8 |
ENST00000334464 |
hsa-mir-891b |
ChrX:145082618-145082639[-] |
PDZD8 |
ENST00000334464 |
hsa-mir-99a-5p |
Chr21:17911421-17911442[+] |
PDZD8 |
ENST00000334464 |
hsa-mir-99b-5p |
Chr19:52195871-52195892[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|